The Rise of Orphan Drugs and Patient Advocacy

added blog Health

2026-01-22 11:48:20 -

For a long time, pharmaceutical companies ignored rare diseases because the "market" was too small to be profitable. This led to the "Orphan Drug" designation—a series of government incentives designed to make rare disease research financially viable. Today, we are seeing the fruits of that policy. What was once a neglected corner of medicine is now one of the most innovative and...

0 Comments 0 Shares 14 Views 0 Reviews